Skip to main content
Knowledge4Policy
Knowledge for policy

Supporting policy with scientific evidence

We mobilise people and resources to create, curate, make sense of and use knowledge to inform policymaking across Europe.

  • Dataset | 22 Jan 2021

Healthcare costs of CVD and cancer in the European countries

Estimated country-based healthcare costs of CVD (total, IHD and cerebrovascular disease) in the EU in 2015 and cancer in the EU, Iceland, Norway and Switzerland in 2018

CVD = cardiovascular disease; IHD = ischaemic heart disease; na = not assessed. Estimates cannot be directly compared between countries as no adjustment for price differentials has been made. Healthcare costs are in million € (estimates).

 

CVD
( EHN 2017 )

IHD
( EHN 2017 )

Cerebrovascular Disease
(
EHN 2017 )

Cancer
(Hofmarcher et al 2020)

Belgium 2,421 399 394 3,240
Bulgaria 344 57 48 320
Czechia 1,481 212 366 1,084
Denmark 962 180 136 1,499
Germany 28,306 4,776 5,651 25,537
Estonia 178 31 43 96
Ireland 857 158 144 1,139
Greece 1,948 369 356 942
Spain 9,243 1,517 1,245 5,245
France 15,195 2,048 1,973 18,707
Croatia 242 46 37 249
Italy 15,708 2,726 3,196 10,374
Cyprus 80 21 8 90
Latvia 130 28 21 111
Lithuania 226 54 42 196
Luxembourg 162 27 24 221
Hungary 1,512 247 276 618
Malta 48 9 9 74
Netherlands 5,527 1,339 844 5,309
Austria 2,522 510 508 2,553
Poland 4,352 836 561 2,185
Portugal 1,174 202 160 991
Romania 1,274 164 163 712
Slovenia 247 40 36 234
Slovakia 657 139 110 428
Finland 1,999 303 721 844
Sweden 1,664 272 336 1,907
United Kingdom 12,348 2,166 2,652 11,691
EU 110,807 18,876 20,060 96,596
Iceland - - - 69
Norway - - - 1,575
Switzerland - - - 4,366